Publication:
Prevalence And Risk Factors Of Drug-induced Gingival Overgrowth In Hypertensive Patients

Simple item page
dc.contributor.authorHaslina Taiben_US
dc.contributor.authorMuhammad Haziq Mohd Radzwanen_US
dc.contributor.authorMuhammad Annurdin Sabarudinen_US
dc.contributor.authorWan Majdiah Wan Mohamaden_US
dc.contributor.authorNoraini Mohamaden_US
dc.date.accessioned2024-05-28T04:21:28Z
dc.date.available2024-05-28T04:21:28Z
dc.date.issued2021
dc.date.submitted2022-2-15
dc.descriptionJournal of Dentistry Indonesia 2021, Vol. 28, No. 1, 8-14en_US
dc.description.abstractGingival overgrowth (GO) or enlargement is an unwanted effect occurring on the gingiva that commonly associated with medications. Hypertension is a global burden systemic conditions and showed high prevalent and more patients are taking antihypertensive drugs. Objective: This study aimed to assess the prevalence of drug-induced gingival overgrowth (DIGO) and its associated risk factors among hypertensive patients attending Hospital Universiti Sains Malaysia, Kelantan, Malaysia. Methods: A total of 42 patients with the mean age of 57.1 (SD=9.3) years had participated in this cross-sectional study. They were recruited if they had consumed anti-hypertensive agents for at least 6 months. Demographic data and oral hygiene status were recorded and the presence of DIGO was assessed based on clinical index for gingival overgrowth. Data were analyzed using SPSS version 24.0 with p < 0.05 is considered statistically significant. Results: Majority of patients were taking calcium channel blockers (CCB) (81.0%) with amlodipine reported as the most common antihypertensive prescribed (47.6%). About 52% presented with DIGO and among them 55.9% were in those on CCB by which 9.5% presented with clinically significant enlargement. Except for gingivitis, oral hygiene status and demographic data were not significant risk factors for DIGO (p > 0.05). Conclusion: We found that DIGO is prevalent among hypertensive patients on CCB and its occurrence is coexists with gingivitis. Therefore, periodontal assessment is recommended among these patients for early detection and management of drug-induced gingival overgrowth.en_US
dc.identifier.citationTaib, H., Mohd Radzwan, M., Sabaruddin, M., Wan Mohamad, W., & Mohamad, N. Prevalence and Risk Factors of Drug-induced Gingival Overgrowth in Hypertensive Patients. J Dent Indones. 2021;28(1): 8-14en_US
dc.identifier.doi10.14693/jdi.v28i1.1166
dc.identifier.epage14
dc.identifier.issn1693-9697
dc.identifier.issue1
dc.identifier.other2105-3
dc.identifier.spage8
dc.identifier.urihttps://scholarhub.ui.ac.id/jdi/vol28/iss1/2/
dc.identifier.urihttps://oarep.usim.edu.my/handle/123456789/5328
dc.identifier.volume28
dc.language.isoenen_US
dc.publisherJournal of Dentistry Indonesiaen_US
dc.relation.ispartofJournal of Dentistry Indonesiaen_US
dc.subjectGingival overgrowth, drug-induced gingival enlargement, calcium channel blocker, anti-hypertensive agentsen_US
dc.titlePrevalence And Risk Factors Of Drug-induced Gingival Overgrowth In Hypertensive Patientsen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Prevalence And Risk Factors Of Drug-induced Gingival Overgrowth In Hypertensive Patients.pdf
Size:
456.21 KB
Format:
Adobe Portable Document Format
Download

Collections

Other Publications